Showing 121-140 of 371 for: Cochrane Systematic Reviews > Oncology 
- Exercise interventions on health‐related quality of life for cancer survivors
Cochrane Systematic Reviews, 15-Aug-2012
Cancer survivors experience numerous disease and treatment-related adverse outcomes and poorer health-related quality of life (HRQoL). Exercise interventions are hypothesized to alleviate these adverse outcomes. HRQoL and its domains are important measure
- Exercise interventions on health‐related quality of life for people with cancer during active treatment
Cochrane Systematic Reviews, 15-Aug-2012
People with cancer undergoing active treatment experience numerous disease- and treatment-related adverse outcomes and poorer health-related quality of life (HRQoL). Exercise interventions are hypothesized to alleviate these adverse outcomes. HRQoL and it
- Extent of lymph node dissection for adenocarcinoma of the stomach
Cochrane Systematic Reviews, 12-Aug-2015
The impact of lymphadenectomy extent on the survival of patients with primary resectable gastric carcinoma is debated.
- First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies
Cochrane Systematic Reviews, 14-Aug-2012
Several clinical studies have compared single with tandem (also called double) autologous stem cell transplantation (ASCT) as first-line treatment in patients with symptomatic multiple myeloma (MM), one of the leading indications for ASCT worldwide.
- Fluid and pharmacological agents for adhesion prevention after gynaecological surgery
Cochrane Systematic Reviews, 19-Jul-2020
Adhesions are fibrin bands that are a common consequence of gynaecological surgery. They are caused by conditions that include pelvic inflammatory disease and endometriosis. Adhesions are associated with comorbidities, including pelvic pain, subfertility,
- Follow‐up strategies for patients treated for non‐metastatic colorectal cancer
Cochrane Systematic Reviews, 4-Sep-2019
This is the fourth update of a Cochrane Review first published in 2002 and last updated in 2016.?
It is common clinical practice to follow patients with colorectal cancer for several years following their curative surgery or adjuvant therapy, or both. Des
- Follow‐up strategies for women treated for early breast cancer
Cochrane Systematic Reviews, 27-May-2016
Follow-up examinations are commonly performed after primary treatment for women with breast cancer. They are used to detect recurrences at an early (asymptomatic) stage. This is an update of a Cochrane review first published in 2000.
- Fully intermittent dosing with drugs for treating tuberculosis in adults
Cochrane Systematic Reviews, 23-Oct-2001
The number of people infected with tuberculosis continues to rise worldwide. Rifampicin-containing treatment regimens can achieve high cure rates. Intermittent drug treatment delivered in the community has the potential to improve adherence to treatment.
- Ganoderma lucidum (Reishi mushroom) for cancer treatment
Cochrane Systematic Reviews, 5-Apr-2016
Ganoderma lucidum is a natural medicine that is widely used and recommended by Asian physicians and naturopaths for its supporting effects on immune system. Laboratory research and a handful of preclinical trials have suggested that G. lucidum carries pro
- Gemcitabine for unresectable, locally advanced or metastatic bladder cancer
Cochrane Systematic Reviews, 1-Mar-2011
The prognosis for unresectable, locally advanced or metastatic transitional cell carcinoma of the bladder is poor with most patients succumbing to their disease within 2 to 3 years. Clinical management at this stage of the disease is palliative with syste
- Granulopoiesis‐stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
Cochrane Systematic Reviews, 8-Oct-2008
Granulopoiesis-stimulating factors, such as granulocyte-colony-stimulating factor (G-CSF) and granulocyte-macrophage-colony-stimulating factor (GM-CSF), are being used to prevent febrile neutropenia and infection in patients undergoing treatment for malig
- Green tea (Camellia sinensis) for the prevention of cancer
Cochrane Systematic Reviews, 2-Mar-2020
This review is an update of a previously published review in the Cochrane Database of Systematic Reviews (2009, Issue 3).Tea is one of the most commonly consumed beverages worldwide. Teas from the plant Camellia sinensis can be grouped into green, black a
- Haloperidol for the treatment of nausea and vomiting in palliative care patients
Cochrane Systematic Reviews, 2-Nov-2015
Nausea and vomiting are common symptoms in patients with terminal, incurable illnesses. Both nausea and vomiting can be distressing. Haloperidol is commonly prescribed to relieve these symptoms. This is an updated version of the original Cochrane review p
- Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
Cochrane Systematic Reviews, 26-Jan-2004
Colorectal surgery implies higher risk of postoperative thromboembolic complications as deep venous thrombosis (DVT) and pulmonary embolism (PE) than general surgery. The best prophylaxis in general surgery is heparin and graded compression stockings. No
- Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver
Cochrane Systematic Reviews, 18-Oct-2006
Colorectal cancer metastatic to the liver, when technically feasible, is resected with a moderate chance of cure. The most common site of failure after resection is within the remaining liver. With this pattern of clinical failure in mind and in order to
- Hepatic late adverse effects after antineoplastic treatment for childhood cancer
Cochrane Systematic Reviews, 15-Apr-2019
Survival rates have greatly improved as a result of more effective treatments for childhood cancer. Unfortunately, the improved prognosis has been accompanied by the occurrence of late, treatment-related complications. Liver complications are common durin
- High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer
Cochrane Systematic Reviews, 9-Oct-2014
This is an updated version of the original Cochrane review published in 2010 (Issue 7).
- High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
Cochrane Systematic Reviews, 20-May-2016
Overall survival rates are disappointing for women with early poor prognosis breast cancer. Autologous transplantation of bone marrow or peripheral stem cells (in which the woman is both donor and recipient) has been considered a promising technique becau
- High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer
Cochrane Systematic Reviews, 20-Jul-2005
Although metastatic breast cancer is often responsive to conventional chemotherapy, it remains ultimately incurable. Autologous transplantation of bone marrow or peripheral stem cells (in which the patient is both donor and recipient) has been considered
- High‐dose chemotherapy and autologous haematopoietic stem cell rescue for children with high‐risk neuroblastoma
Cochrane Systematic Reviews, 5-Oct-2015
Despite the development of new treatment options, the prognosis of high-risk neuroblastoma patients is still poor; more than half of patients experience disease recurrence. High-dose chemotherapy and haematopoietic stem cell rescue (i.e. myeloablative the
